ReviewCancer medicine2025
Strategies Beyond 3rd EGFR-TKI Acquired Resistance: Opportunities and Challenges.
Xuexue Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it
ReviewCancer medicine2025
Xuexue Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.